Leaflet: information for the user
Imigran Neo 50 mg film-coated tablets
Sumatriptan (as sumatriptan succinate)
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
-Keep this leaflet, as you may need to read it again.
-If you have any questions, consult your doctor or pharmacist.
-This medicine has been prescribed for you only, and you must not give it to otherseven if they have the same symptoms as you, as it may harm them.
-Ifyouexperienceside effects, consult your doctor or pharmacist, even if the side effects are not listed in this leaflet. See section 4.
Imigran Neo contains the active ingredient sumatriptan and belongs to a group of medicines called triptans (also known as 5-HT1 receptor agonists).
This medicine is indicated to relieve headache pain and other symptoms of a migraine attack.
The dilation of blood vessels in the head is considered to be the cause of the headache that appears in a migraine. This medicine constricts the blood vessels in the head and relieves the symptoms of a migraine.
Do not take Imigran Neo
If any of these cases apply to you
?Inform your doctor, and do not use Imigran Neo.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Imigran Neo.
Before taking Imigran Neo, your doctor needs to knowif you have any extra risk factors for heart disease:
In very rare cases, people have developed severe heart problems after usingImigran Neo, even if they did not have any signs of heart disease beforehand. If any of the above points happen to you, it may mean that you have a higher risk of developing heart disease, so
?Inform your doctor to check your heart functionbefore Imigran Neo is prescribed for you.
If you have high blood pressure
Imigran may not be suitable for you:
?Consult your doctor or pharmacist before using Imigran Neo.
If you have kidney or liver disease
?Consult your doctor or pharmacist before using Imigran Neo.
If you have a history of seizures(convulsions)
Or if you have other conditions that may make you more likely to have seizures – for example, a head injury or alcoholism.
?Inform your doctor to be closely monitored.
If you are allergic to sulphonamide antibiotics
If you are, you may also be allergic toImigran Neo. If you know you are allergic to antibiotics, but are not sure if it is a sulphonamide
?Inform your doctor or pharmacist before usingImigran Neo.
If you are taking antidepressants called SSRIs(Selective Serotonin Reuptake Inhibitors)orSNRIs(Serotonin and Noradrenaline Reuptake Inhibitors)
?Inform your doctor or pharmacist before usingImigran Neo.See also below,Other medicines and Imigran Neo.
If you useImigran Neofrequently
A frequent use ofImigran Neomay make your headaches worse.
?Inform your doctor if this happens to you.Your doctor may recommend that you stop usingImigran Neo.
If you feel pain or pressure in your chest after using Imigran Neo
These effects may intensify but usually pass quickly. If they do not pass quickly or become more severe:
?Get medical help immediately.See section 4 of this leaflet for more information about these possible side effects.
Other medicines and Imigran Neo
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medicine. This includes any herbal remedies or medicines that have been bought without a prescription.
Some medicines should not be taken with Imigran Neo and others may cause side effects if taken with Imigran Neo.Inform your doctor if you are taking other medicines, such as:
Fertility, pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, or are planning to become pregnant, consult your doctor before using this medicine. There is limited information on the safety of Imigran Neo in pregnant women, although so far there is no evidence that it increases the risk of birth defects. Your doctor will assess with you whether you should or should not use Imigran Neo while pregnant.
You should not breastfeed your baby for at least12 hours after taking Imigran Neo. If you express milk during this time, discard the milk and do not give it to your baby.
Driving and using machines
This medicine, like migraine, can cause drowsiness. If you experience these effects, avoid driving or using machines as it may be dangerous.
Imigran Neo contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is, essentially “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Only use Imigran Neo after your migraine headache has started.
Do not use Imigran Neo to prevent a migraine attack.
Remember to take your medication.
Your doctor will indicate the duration of your treatment with Imigran Neo. Do not discontinue treatment before.
The tablets should be taken as soon as the symptoms of migraine appear; however, they can be taken at any time during an attack.
Administration is not recommended for children, adolescents under 18 years old, or elderly patients.
The recommended dose of Imigran Neo is one 50 mg tablet, although some patients may need a dose of 100 mg (two 50 mg tablets).
If you obtain an improvement of symptoms after the first dose, but symptoms reappear, you can take a second Imigran Neo tablet, at least two hours after the first dose.
If you do not obtain improvement after administration of a dose, do not take a second dose for the same migraine attack. Imigran Neo can be taken for subsequent attacks.
If you do not observe relief of symptoms with Imigran Neo, you can take your usual medication for headache, as long as it does not contain ergotamine or dihydroergotamine.
Swallow the tablets whole, with a little water.
If you take more Imigran Neo than you should:
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicological Information Service, phone: 91 5620420, indicating the medication and the amount ingested.
If you forgot to take Imigran Neo
Do not take a double dose to compensate for the missed doses.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, Imigran Neocan cause side effects, although not everyone will experience them.
Some of these symptoms may be caused by the migraine itself.
Allergic reactions: seek medical help immediately
If you notice any of these symptoms shortly after usingImigran Neo:
?Do not use it again.Contact your doctor immediately.
Frequent side effects
(affects up to1 in 10people)
If these effects persist or worsen(especially chest pain):
?Seek urgent medical help.In a reduced number of people, these symptoms may be caused by heart attacks.
Other frequent side effects include:
Rare side effects
(affects up to1 in 10,000people)
Some patients may experience any of the following side effects, but the frequency with which they occur is unknown
Reporting side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not store at a temperature above 86°F (30°C).
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. By doing so, you will help protect the environment.
The active ingredient is sumatriptan (as sumatriptan succinate). Each tablet contains 50 mg of sumatriptan (as sumatriptan succinate).
The other components are calcium hydrogen phosphate, microcrystalline cellulose, sodium hydrogen carbonate, sodium croscarmellose, magnesium stearate, hypromellose (E464), titanium dioxide (E171), iron oxide red (E172), and triacetin glycerol.
Appearance of the product and contents of the packaging
Imigran Neo is presented in the form of coated tablets. The tablets are triangular in shape, pink in color. Each package contains 4 tablets.
Holder of the marketing authorization and responsible manufacturer
Holder of the marketing authorization:
GlaxoSmithKline, S.A.
P.T.M. C/ Severo Ochoa, 2
28760 Tres Cantos (Madrid)
Phone: +34 900 202 700
Responsible manufacturer:
Delpharm Poznan Spólka Akcyjna
ul. Grunwaldzka 189
60-322 Poznan
Poland
Last review date of this leaflet: September 2020.
The detailed and updated information on this medication is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.